Not available outside of the UK & Ireland.
Application
Anti-HMMR Antibody/CD168 detects level of HMMR/CD168 & has been published & validated for use in HMMR/CD168.
General description
Hyaluronan mediated motility receptor (HMMR) is also called Receptor for hyaluronan-mediated motility (RHAMM), Intracellular hyaluronic acid-binding protein (IHABP), and CD_antigen 168 (CD168). HMMR is involved in cell motility, and is also linked to cellular transformation and metastasis formation, regulation of extracellular-regulated kinase (ERK) activity. HMMR is expressed in breast cancer cell lines and in normal breast tissue.
Immunogen
KLH-conjugated linear peptide corresponding to the of human HMMR.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Quality
Evaluated by Western Blotting in MDA-MB-435 cell lysate.
Western Blotting Analysis: A 1:1,000 dilution of this antibody detected HMMR in 10 µg of MDA-MB-435 cell lysate.
Target description
~85 kDa observed
This product has met the following criteria to qualify for the following awards: